Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, United States; Center for Health Systems Effectiveness, Oregon Health & Science University, Portland, OR, United States.
Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, United States; Center for Health Systems Effectiveness, Oregon Health & Science University, Portland, OR, United States.
Contraception. 2024 Oct;138:110512. doi: 10.1016/j.contraception.2024.110512. Epub 2024 Jun 7.
This study aimed to determine the factors contributing to racial and ethnic disparities in the use of immediate postpartum, long-acting reversible contraception (IPP LARC) and permanent contraception among Medicaid recipients.
We conducted a cross-sectional study using 3 years of national Medicaid claims data to examine the rates of IPP LARC use alone and a composite measure of postpartum permanent contraception and IPP LARC within 7 days of delivery by race and ethnicity. We used a Blinder-Oaxaca model to quantify the extent to which medical complexity, age, rurality, mode of delivery, and year explained differences in outcomes among different minoritized groups in comparison to non-Hispanic White women.
Our study sample contained 1,729,663 deliveries occurring from 2016 through 2018 among 1,605,199 people living in 16 states. IPP LARC use rates were highest among Black (2.2%), followed by American Indian and Alaska Native at 2.1% and Hawaiian/Pacific Islander beneficiaries at 1.9%, Hispanic (all races) at 1.2%, and Asian at 1.0%. IPP LARC was lowest among White beneficiaries (0.8%). Medical complexity, age, rurality, year, and mode of delivery explained only 12.3% of the difference in IPP LARC rates between Black and White beneficiaries. Postpartum permanent contraception was highest among White (7.6%), Hispanic (7.2%), and American Indian and Alaska Native (6.8%), followed by Black (6.3%), Hawaiian/Pacific Islander (5.1%) and lowest among Asian women (4.1%). When we examined the use of IPP LARC or postpartum permanent contraception together, these same factors explained 94.4% of the differences between Black and White beneficiaries.
While differences in the use of IPP LARC by race and ethnicity were identified, our findings suggest that overall use of inpatient highly effective contraception are similar across racial and ethnic groups.
When IPP LARC and postpartum permanent contraception are examined jointly, their use is similar across racial and ethnic groups.
本研究旨在确定导致医疗补助受种者中即刻产后长效可逆避孕(IPP LARC)和永久性避孕种族和民族差异的因素。
我们使用 3 年的全国医疗补助索赔数据进行了一项横断面研究,以检查种族和族裔群体中单独使用 IPP LARC 以及在分娩后 7 天内使用产后永久性避孕和 IPP LARC 的复合指标的比率。我们使用 Blinder-Oaxaca 模型来量化在比较非西班牙裔白人女性时,医疗复杂性、年龄、农村地区、分娩方式和年份在不同少数民族群体之间的结果差异中有多大程度可以解释。
我们的研究样本包括 2016 年至 2018 年期间在 16 个州生活的 1605199 人中的 1729663 次分娩。黑人(2.2%)、美国印第安人和阿拉斯加原住民(2.1%)和夏威夷/太平洋岛民(1.9%)、西班牙裔(所有种族)(1.2%)和亚裔(1.0%)的 IPP LARC 使用率最高。白人(0.8%)的 IPP LARC 使用率最低。医疗复杂性、年龄、农村地区、年份和分娩方式仅解释了黑人与白人之间 IPP LARC 率差异的 12.3%。产后永久性避孕措施在白人(7.6%)、西班牙裔(7.2%)和美国印第安人和阿拉斯加原住民(6.8%)中最高,其次是黑人(6.3%)、夏威夷/太平洋岛民(5.1%),而亚裔女性(4.1%)最低。当我们检查 IPP LARC 或产后永久性避孕的联合使用时,这些相同的因素解释了黑人与白人之间 94.4%的差异。
尽管确定了种族和族裔之间 IPP LARC 使用的差异,但我们的研究结果表明,在不同种族和族裔群体中,使用住院高度有效的避孕措施总体上是相似的。
当联合检查 IPP LARC 和产后永久性避孕时,它们在不同种族和族裔群体中的使用情况相似。